By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Life Technologies today said that it has begun clinical trials on a sequencing-based platform for human leukocyte antigen typing.

The firm said that it has contracted with a clinical research organization to oversee the studies at accredited HLA typing labs in the US. Researchers at those sites will evaluate six gene regions of the HLA system using the Applied Biosystems 3500 Dx Genetic Analyzer, SeCore kits, and uType Dx software.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.